NEW YORK – Illumina said on Tuesday that China's National Medical Products Administration (NMPA) has approved the firm's NextSeq 550Dx instrument for genetic testing and diagnosis.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.